You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Innovative Designs for Reliable Electro-Explosive Ordnance Devices

    SBC: SEACORP, LLC            Topic: MDA12031

    Missiles, use electro-explosive devices (EEDs) to perform mulitple functions during operation. This effort seeks ways to improve on the EED"s reliability and lower the failure or inadvertent activation rate of these devices. During Phase I, SEA CORP investigated replacing EEDs with commercial off the shelf (COTS) automotive airbag inflators to perform the required pneumatic functions of variou ...

    SBIR Phase II 2014 Department of DefenseMissile Defense Agency
  2. Web-Based Training in Alcohol SBIRT for Youth Aged 9-18

    SBC: Oregon Center For Applied Science, Inc            Topic: NIAAA

    DESCRIPTION (provided by applicant): Underage alcohol consumption is a public health concern with numerous negative sequelae, including adoption of other risky behaviors (smoking, other drug use, at-risk sexual behavior, drinking and driving), increased rates of depression or suicidal ideation, poor academic achievement, and behavioral problems (delinquency, violence, crime). Adolescents who drink ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Mobile Intervention to Enhance Physical Activity in the Chronically Ill

    SBC: Oregon Center For Applied Science, Inc            Topic: NIA

    PROJECT SUMMARY This project aims to fill the urgent need for a safe and engaging intervention that promotes physical activity in a population of patients with chronic diseases (e.g., diabetes, asthma, osteoarthritis, and chronic heart failure). Compelling evidence suggests that physical activity is an effective therapeutic intervention for numerous chronic diseases. However, in spite of the wide ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Microfluidic screening devices for health-span extending drugs

    SBC: NEMAMETRIX, INC            Topic: NIA

    Aging, the progressive degeneration of body and mind, is a universal problem marked by a decline in tissue organization and function, and an increase in the likelihood of death. Progress in understanding the cellular and molecular basis of aging is rapidlyaccelerating, following the discovery that several well-known model organisms age in many of the same ways as humans. In addition to their contr ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. XHA-A Novel Tolerance Therapeutic for Allergic Rhinitis

    SBC: VIRTICI LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): The goal of this project is to extend the development of a novel compound that can reprogram memory T lymphocytes to induce tolerance in allergic rhinitis (AR). AR is one of the most common chronic diseases in the United States (US) and is estimated to affect more than 50 million people [1,2]. As a result, the annual US economic burden of AR exceeds 12 billio ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Non-invasive Diagnostic Platform Development for Celiac Disease Remission Status

    SBC: ADAPTIVE BIOTECHNOLOGIES CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): The purpose of this proposal is to adapt a technology that we have developed for monitoring residual disease in leukemia patients to monitor residual autoimmune disease in Celiac Disease patients. Celiac disease hasa significant burden on quality of life, as it is one of the most frequent autoimmune diseases, with an estimated prevalence of approximately 1% ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Development and Commercialization of an Innovative Rapid HIV-1 Incidence Assay

    SBC: SEDIA BIOSCIENCES CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): The objective of this project is to develop a commercially viable point of care Rapid HIV-1 Incidence Assay and establish its suitability for determination of recency of HIV-1 infection in whole blood, plasma, serum specimens for epidemiological, research and surveillance purposes. It is further intended to determine the feasibility of the application of the as ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. An effector memory T cell-based therapeutic cervical cancer vaccine

    SBC: TOMEGAVAX, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): The longterm goal of this project is to utilize cytomegalovirus (CMV) vectors carrying oncogenes of high risk human papillomaviruses (HPV) as novel therapeutic vaccines against cervical cancer. Although recently launched prophylactic vaccines protect against HPV infection, these VLP-based vaccines have not demonstrated significant benefit for individuals who a ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Tumor Tight Junction Opener + Chemotherapy Conjugates to Treat Cancer

    SBC: PAI LIFE SCIENCES INC            Topic: NCI

    Project Summary Tumors survive cancer therapy in part by blocking the entrance and permeation of drugs into the cancer. We have developed a therapeutic, JO-1 , that selectively opens up tumors, which dramatically enhances penetration. This results in markedly increased concentrations of cancer drugs in the tumor, which becomes a sink , thereby reducing drug levels in the rest of the body. JO-1 m ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Development of an Ad5-CEA/Brachyury Vector Approach for Cancer Treatment

    SBC: Etubics Corporation            Topic: NCI

    DESCRIPTION (provided by applicant): With the discovery of new biomarkers associated with tumor development, many of these tumor-associated antigens (TAA) are being utilized in immunotherapeutic modalities designed to induce anti-tumor directed cytotoxicimmune responses. It is increasingly clear that not any one of these TAA is sufficient, as a single entity to develop an immunotherapeutic treatm ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government